Initially, Stirling Products will manufacture 300kgs of tableted products and will gradually increase its production with the signing of more contracts which are now in process.
Stirling Products’ 4,270 square metre pharmaceutical facility is engaged in manufacturing and commercializing prescription, over-the counter, netraceutical, and natural health products.
With current fit-out and configuration the plant has an annual capacity to manufacture and package over 550 million tablets, 5 million bottles and blend up to 1.5 million kg of product.